Exosome Proteomics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510247262

Publication Date:

October 16, 2024

Pages:

143

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Exosome Proteomics Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Exosome Proteomics Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Exosome Proteomics Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Exosome Proteomics Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Exosome Proteomics Service include System Biosciences, HansaBioMed Life Sciences Ltd., QIAGEN Inc., Norgen Biotek Corp., Bio-Techne, AMSBIO LLC, NX Pharmagen, Thermo Fisher Scientific and Sistemic Ltd., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Exosome Proteomics Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Exosome Proteomics Service by region & country, by Type, and by Application.
The Exosome Proteomics Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Proteomics Service.
Market Segmentation
By Company
System Biosciences
HansaBioMed Life Sciences Ltd.
QIAGEN Inc.
Norgen Biotek Corp.
Bio-Techne
AMSBIO LLC
NX Pharmagen
Thermo Fisher Scientific
Sistemic Ltd.
Exosome Diagnostics
Lonza Group Ltd.
Evox Therapeutics Ltd.
Evomic Science LLC
ExoCyte Therapeutics LLC
Optofluidics, Inc.
New England Biolabs
Izon Science Ltd.
Miltenyi Biotec GmbH
Codiak BioSciences
Ology Bioservices Inc.
Segment by Type:
Separate
Identification and Characterization
Quantitative Analysis
Content Analysis
Functional Analysis
Segment by Application
Biomarker Discovery
Drug Delivery
Disease Diagnosis and Monitoring
Personalized Medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Exosome Proteomics Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Exosome Proteomics Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Exosome Proteomics Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Exosome Proteomics Service Product Introduction
1.2 Global Exosome Proteomics Service Market Size Forecast
1.3 Exosome Proteomics Service Market Trends & Drivers
1.3.1 Exosome Proteomics Service Industry Trends
1.3.2 Exosome Proteomics Service Market Drivers & Opportunity
1.3.3 Exosome Proteomics Service Market Challenges
1.3.4 Exosome Proteomics Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Exosome Proteomics Service Players Revenue Ranking (2023)
2.2 Global Exosome Proteomics Service Revenue by Company (2019-2024)
2.3 Key Companies Exosome Proteomics Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Exosome Proteomics Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Exosome Proteomics Service
2.6 Exosome Proteomics Service Market Competitive Analysis
2.6.1 Exosome Proteomics Service Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Exosome Proteomics Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Proteomics Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Separate
3.1.2 Identification and Characterization
3.1.3 Quantitative Analysis
3.1.4 Content Analysis
3.1.5 Functional Analysis
3.2 Global Exosome Proteomics Service Sales Value by Type
3.2.1 Global Exosome Proteomics Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Exosome Proteomics Service Sales Value, by Type (2019-2030)
3.2.3 Global Exosome Proteomics Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biomarker Discovery
4.1.2 Drug Delivery
4.1.3 Disease Diagnosis and Monitoring
4.1.4 Personalized Medicine
4.1.5 Others
4.2 Global Exosome Proteomics Service Sales Value by Application
4.2.1 Global Exosome Proteomics Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Exosome Proteomics Service Sales Value, by Application (2019-2030)
4.2.3 Global Exosome Proteomics Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Exosome Proteomics Service Sales Value by Region
5.1.1 Global Exosome Proteomics Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Exosome Proteomics Service Sales Value by Region (2019-2024)
5.1.3 Global Exosome Proteomics Service Sales Value by Region (2025-2030)
5.1.4 Global Exosome Proteomics Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Exosome Proteomics Service Sales Value, 2019-2030
5.2.2 North America Exosome Proteomics Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Exosome Proteomics Service Sales Value, 2019-2030
5.3.2 Europe Exosome Proteomics Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Exosome Proteomics Service Sales Value, 2019-2030
5.4.2 Asia Pacific Exosome Proteomics Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Exosome Proteomics Service Sales Value, 2019-2030
5.5.2 South America Exosome Proteomics Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Exosome Proteomics Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Exosome Proteomics Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Exosome Proteomics Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Exosome Proteomics Service Sales Value
6.3 United States
6.3.1 United States Exosome Proteomics Service Sales Value, 2019-2030
6.3.2 United States Exosome Proteomics Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Exosome Proteomics Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Exosome Proteomics Service Sales Value, 2019-2030
6.4.2 Europe Exosome Proteomics Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Exosome Proteomics Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Exosome Proteomics Service Sales Value, 2019-2030
6.5.2 China Exosome Proteomics Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Exosome Proteomics Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Exosome Proteomics Service Sales Value, 2019-2030
6.6.2 Japan Exosome Proteomics Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Exosome Proteomics Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Exosome Proteomics Service Sales Value, 2019-2030
6.7.2 South Korea Exosome Proteomics Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Exosome Proteomics Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Exosome Proteomics Service Sales Value, 2019-2030
6.8.2 Southeast Asia Exosome Proteomics Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Exosome Proteomics Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Exosome Proteomics Service Sales Value, 2019-2030
6.9.2 India Exosome Proteomics Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Exosome Proteomics Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 System Biosciences
7.1.1 System Biosciences Profile
7.1.2 System Biosciences Main Business
7.1.3 System Biosciences Exosome Proteomics Service Products, Services and Solutions
7.1.4 System Biosciences Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.1.5 System Biosciences Recent Developments
7.2 HansaBioMed Life Sciences Ltd.
7.2.1 HansaBioMed Life Sciences Ltd. Profile
7.2.2 HansaBioMed Life Sciences Ltd. Main Business
7.2.3 HansaBioMed Life Sciences Ltd. Exosome Proteomics Service Products, Services and Solutions
7.2.4 HansaBioMed Life Sciences Ltd. Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.2.5 HansaBioMed Life Sciences Ltd. Recent Developments
7.3 QIAGEN Inc.
7.3.1 QIAGEN Inc. Profile
7.3.2 QIAGEN Inc. Main Business
7.3.3 QIAGEN Inc. Exosome Proteomics Service Products, Services and Solutions
7.3.4 QIAGEN Inc. Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.3.5 Norgen Biotek Corp. Recent Developments
7.4 Norgen Biotek Corp.
7.4.1 Norgen Biotek Corp. Profile
7.4.2 Norgen Biotek Corp. Main Business
7.4.3 Norgen Biotek Corp. Exosome Proteomics Service Products, Services and Solutions
7.4.4 Norgen Biotek Corp. Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.4.5 Norgen Biotek Corp. Recent Developments
7.5 Bio-Techne
7.5.1 Bio-Techne Profile
7.5.2 Bio-Techne Main Business
7.5.3 Bio-Techne Exosome Proteomics Service Products, Services and Solutions
7.5.4 Bio-Techne Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.5.5 Bio-Techne Recent Developments
7.6 AMSBIO LLC
7.6.1 AMSBIO LLC Profile
7.6.2 AMSBIO LLC Main Business
7.6.3 AMSBIO LLC Exosome Proteomics Service Products, Services and Solutions
7.6.4 AMSBIO LLC Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.6.5 AMSBIO LLC Recent Developments
7.7 NX Pharmagen
7.7.1 NX Pharmagen Profile
7.7.2 NX Pharmagen Main Business
7.7.3 NX Pharmagen Exosome Proteomics Service Products, Services and Solutions
7.7.4 NX Pharmagen Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.7.5 NX Pharmagen Recent Developments
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Profile
7.8.2 Thermo Fisher Scientific Main Business
7.8.3 Thermo Fisher Scientific Exosome Proteomics Service Products, Services and Solutions
7.8.4 Thermo Fisher Scientific Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.8.5 Thermo Fisher Scientific Recent Developments
7.9 Sistemic Ltd.
7.9.1 Sistemic Ltd. Profile
7.9.2 Sistemic Ltd. Main Business
7.9.3 Sistemic Ltd. Exosome Proteomics Service Products, Services and Solutions
7.9.4 Sistemic Ltd. Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.9.5 Sistemic Ltd. Recent Developments
7.10 Exosome Diagnostics
7.10.1 Exosome Diagnostics Profile
7.10.2 Exosome Diagnostics Main Business
7.10.3 Exosome Diagnostics Exosome Proteomics Service Products, Services and Solutions
7.10.4 Exosome Diagnostics Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.10.5 Exosome Diagnostics Recent Developments
7.11 Lonza Group Ltd.
7.11.1 Lonza Group Ltd. Profile
7.11.2 Lonza Group Ltd. Main Business
7.11.3 Lonza Group Ltd. Exosome Proteomics Service Products, Services and Solutions
7.11.4 Lonza Group Ltd. Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.11.5 Lonza Group Ltd. Recent Developments
7.12 Evox Therapeutics Ltd.
7.12.1 Evox Therapeutics Ltd. Profile
7.12.2 Evox Therapeutics Ltd. Main Business
7.12.3 Evox Therapeutics Ltd. Exosome Proteomics Service Products, Services and Solutions
7.12.4 Evox Therapeutics Ltd. Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.12.5 Evox Therapeutics Ltd. Recent Developments
7.13 Evomic Science LLC
7.13.1 Evomic Science LLC Profile
7.13.2 Evomic Science LLC Main Business
7.13.3 Evomic Science LLC Exosome Proteomics Service Products, Services and Solutions
7.13.4 Evomic Science LLC Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.13.5 Evomic Science LLC Recent Developments
7.14 ExoCyte Therapeutics LLC
7.14.1 ExoCyte Therapeutics LLC Profile
7.14.2 ExoCyte Therapeutics LLC Main Business
7.14.3 ExoCyte Therapeutics LLC Exosome Proteomics Service Products, Services and Solutions
7.14.4 ExoCyte Therapeutics LLC Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.14.5 ExoCyte Therapeutics LLC Recent Developments
7.15 Optofluidics, Inc.
7.15.1 Optofluidics, Inc. Profile
7.15.2 Optofluidics, Inc. Main Business
7.15.3 Optofluidics, Inc. Exosome Proteomics Service Products, Services and Solutions
7.15.4 Optofluidics, Inc. Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.15.5 Optofluidics, Inc. Recent Developments
7.16 New England Biolabs
7.16.1 New England Biolabs Profile
7.16.2 New England Biolabs Main Business
7.16.3 New England Biolabs Exosome Proteomics Service Products, Services and Solutions
7.16.4 New England Biolabs Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.16.5 New England Biolabs Recent Developments
7.17 Izon Science Ltd.
7.17.1 Izon Science Ltd. Profile
7.17.2 Izon Science Ltd. Main Business
7.17.3 Izon Science Ltd. Exosome Proteomics Service Products, Services and Solutions
7.17.4 Izon Science Ltd. Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.17.5 Izon Science Ltd. Recent Developments
7.18 Miltenyi Biotec GmbH
7.18.1 Miltenyi Biotec GmbH Profile
7.18.2 Miltenyi Biotec GmbH Main Business
7.18.3 Miltenyi Biotec GmbH Exosome Proteomics Service Products, Services and Solutions
7.18.4 Miltenyi Biotec GmbH Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.18.5 Miltenyi Biotec GmbH Recent Developments
7.19 Codiak BioSciences
7.19.1 Codiak BioSciences Profile
7.19.2 Codiak BioSciences Main Business
7.19.3 Codiak BioSciences Exosome Proteomics Service Products, Services and Solutions
7.19.4 Codiak BioSciences Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.19.5 Codiak BioSciences Recent Developments
7.20 Ology Bioservices Inc.
7.20.1 Ology Bioservices Inc. Profile
7.20.2 Ology Bioservices Inc. Main Business
7.20.3 Ology Bioservices Inc. Exosome Proteomics Service Products, Services and Solutions
7.20.4 Ology Bioservices Inc. Exosome Proteomics Service Revenue (US$ Million) & (2019-2024)
7.20.5 Ology Bioservices Inc. Recent Developments
8 Industry Chain Analysis
8.1 Exosome Proteomics Service Industrial Chain
8.2 Exosome Proteomics Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Exosome Proteomics Service Sales Model
8.5.2 Sales Channel
8.5.3 Exosome Proteomics Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

System Biosciences
HansaBioMed Life Sciences Ltd.
QIAGEN Inc.
Norgen Biotek Corp.
Bio-Techne
AMSBIO LLC
NX Pharmagen
Thermo Fisher Scientific
Sistemic Ltd.
Exosome Diagnostics
Lonza Group Ltd.
Evox Therapeutics Ltd.
Evomic Science LLC
ExoCyte Therapeutics LLC
Optofluidics, Inc.
New England Biolabs
Izon Science Ltd.
Miltenyi Biotec GmbH
Codiak BioSciences
Ology Bioservices Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂